Savient Pharmaceuticals marks $62,592 profit for month ended April 30

By Caroline Salls

Pittsburgh, May 20 - Savient Pharmaceuticals, Inc. reported a $62,592 net profit for April on $9,428 in net revenue, according to a monthly operating report filed Tuesday with the Securities and Exchange Commission.

The company had $7.4 million in cash and cash equivalents at April 30.

Debtor Savient Pharma Holdings, Inc. posted a $1 million net loss for the month.

Savient Pharma had $2.24 million in cash and cash equivalents as of April 30.

Savient, an East Brunswick, N.J., pharmaceutical company, filed for bankruptcy on Oct. 15, 2013 in the U.S. Bankruptcy Court for the District of Delaware. The Chapter 11 case number is 13-12680.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.